Literature DB >> 14700612

Treating two concurrent B-cell and T-cell lymphoid neoplasms with alemtuzumab monotherapy.

Niccolò Bolli1, Mauro Di Ianni, Stefano Simonetti, Lorenzo Cerroni, Arcangelo Liso, Brunangelo Falini, Antonio Tabilio.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14700612     DOI： 10.1016/s1470-2045(03)01327-5

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  2 in total

Review 1.  [Mycosis fungoides and B-cell chronic lymphocytic leukemia: an extremely rare coincidence].

Authors:  A Süss; T Wetzig; M Sticherling; A Tannapfel; J C Simon
Journal:  Hautarzt       Date:  2006-10       Impact factor: 0.751

Review 2.  Alemtuzumab for patients with chronic lymphocytic leukaemia.

Authors:  Nicole Skoetz; Kathrin Bauer; Thomas Elter; Ina Monsef; Verena Roloff; Michael Hallek; Andreas Engert
Journal:  Cochrane Database Syst Rev       Date:  2012-02-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.